BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2208163)

  • 1. Cytotoxicity, radiosensitization, antitumor activity, and interaction with hyperthermia of a Co(III) mustard complex.
    Teicher BA; Abrams MJ; Rosbe KW; Herman TS
    Cancer Res; 1990 Nov; 50(21):6971-5. PubMed ID: 2208163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma.
    Herman TS; Teicher BA; Pfeffer MR; Khandekar VS; Korbut TT
    Cancer Res; 1990 Jul; 50(13):3826-31. PubMed ID: 2354434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity, radiosensitization, and DNA interaction of platinum complexes of thiazin and xanthene dyes.
    Teicher BA; Herman TS; Kaufmann ME
    Radiat Res; 1990 Feb; 121(2):187-95. PubMed ID: 2305037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.
    Teicher BA; Herman TS; Holden SA; Epelbaum R; Liu SD; Frei E
    Cancer Res; 1991 Feb; 51(3):780-4. PubMed ID: 1988117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
    Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
    Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined modality therapy with bleomycin, hyperthermia, and radiation.
    Teicher BA; Herman TS; Holden SA
    Cancer Res; 1988 Nov; 48(22):6291-7. PubMed ID: 2460220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of PtCl4(Fast Black)2 with hyperthermia.
    Teicher BA; Herman TS; Pfeffer MR; Alvarez Sotomayor E; Khandekar VS
    Cancer Res; 1989 Nov; 49(22):6208-13. PubMed ID: 2804969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma.
    Teicher BA; Holden SA; al-Achi A; Herman TS
    Cancer Res; 1990 Jun; 50(11):3339-44. PubMed ID: 2334928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA interaction, cytotoxicity, and radiosensitization with PtCl4(Nile Blue)2 and PtCl4(Neutral Red)2.
    Teicher BA; Herman TS; Kaufmann ME
    Radiat Res; 1989 Oct; 120(1):129-39. PubMed ID: 2798776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
    Cantrell JE; Green D; Schein PS
    Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo.
    Teicher BA; Holden SA; Herman TS; Epelbaum R; Pardee AB; Dezube B
    Anticancer Res; 1991; 11(4):1555-60. PubMed ID: 1746913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hypoxia and acidosis on the cytotoxicity of four platinum complexes at normal and hyperthermic temperatures.
    Herman TS; Teicher BA; Collins LS
    Cancer Res; 1988 May; 48(9):2342-7. PubMed ID: 3356002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma.
    Herman TS; Teicher BA; Holden SA; Pfeffer MR; Jones SM
    Cancer Res; 1990 May; 50(9):2734-40. PubMed ID: 2139359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo.
    Herman TS; Teicher BA; Coleman CN
    Cancer Res; 1990 Aug; 50(16):5055-9. PubMed ID: 2379171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo.
    Herman TS; Teicher BA; Chan V; Collins LS; Kaufmann ME; Loh C
    Cancer Res; 1988 May; 48(9):2335-41. PubMed ID: 3356001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical studies and clinical correlation of the effect of alkylating dose.
    Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
    Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of platinum(II) tetrachlorodianion (Fast Black)2 with superhelical DNA and with radiation in vitro and in vivo.
    Teicher BA; Herman TS; Kaufmann ME
    Radiat Res; 1989 Jul; 119(1):134-44. PubMed ID: 2756104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
    Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST
    Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
    Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E
    Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.